Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Open access

Abstract

In the past 8 years, both the International Working Group (IWG) and the US National Institute on Aging-Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's disease (AD) that better define clinical phenotypes and integrate biomarkers into the diagnostic process, covering the full staging of the disease. This Position Paper considers the strengths and limitations of the IWG research diagnostic criteria and proposes advances to improve the diagnostic framework. On the basis of these refinements, the diagnosis of AD can be simplified, requiring the presence of an appropriate clinical AD phenotype (typical or atypical) and a pathophysiological biomarker consistent with the presence of Alzheimer's pathology. We propose that downstream topographical biomarkers of the disease, such as volumetric MRI and fluorodeoxyglucose PET, might better serve in the measurement and monitoring of the course of disease. This paper also elaborates on the specific diagnostic criteria for atypical forms of AD, for mixed AD, and for the preclinical states of AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70090-0

Cites

214 of 214 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 214 references

Cited by

See all 3,321

Metadata

Authors
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M.-O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., & Cummings, J. L.
Affiliations
  • Inserm (FR)
  • Vancouver Coastal Health (CA)
  • University of British Columbia Hospital (CA)
  • Sahlgrenska University Hospital (SE)
  • University of Virginia (US)
  • Douglas Mental Health University Institute (CA)
  • Brigham and Women's Hospital (US)
  • Washington University in St. Louis (US)
  • Vita-Salute San Raffaele University (IT)
  • National Hospital for Neurology and Neurosurgery (GB)
  • University of Antwerp (BE)
  • University of Geneva (CH)
  • UCL Queen Square Institute of Neurology (GB)
  • University of California San Diego (US)
  • University of Kentucky (US)
  • Karolinska University Hospital (SE)
  • Centre Hospitalier Universitaire de Lille (FR)
  • University of California, San Francisco (US)
  • Centre Hospitalier Universitaire de Nice (FR)
  • Austin Hospital (AU)
  • Brown University (US)
  • Centre Hospitalier Sainte-Anne (FR)
  • Université Toulouse III - Paul Sabatier (FR)
  • Maastricht University Medical Centre (NL)
  • University of Southern California (US)
  • NewYork–Presbyterian Hospital (US)
  • Vrije Universiteit Amsterdam (NL)
  • Cleveland Clinic (US)
Corresponding author
Dubois, Bruno
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2014-06
Volume
13
Issue
6
Pages
614-629
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2116709840
Cited by
3,321
References
214
Citations by year
2026: 138 · 2025: 197 · 2024: 240 · 2023: 270 · 2022: 302 · 2021: 361 · 2020: 361 · 2019: 310 · 2018: 308 · 2017: 297 · 2016: 263 · 2015: 218 · 2014: 43
FWCI
208.97
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Columbia Academic Commons (Columbia University)
Funders
  • National Institute for Health and Care Research (NF-SI-0513-10134, NF-SI-0508-10123)
  • Economic and Social Research Council (ES/L001810/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
Alzheimer's disease, Research Diagnostic Criteria, NIA-AA criteria, clinical phenotype, biomarkers, atypical Alzheimer's disease, preclinical Alzheimer's disease, volumetric MRI, FDG-PET, disease staging, diagnostic framework
MeSH terms
Alzheimer Disease, Humans, International Cooperation, Phenotype, Societies, Medical, Biomarkers, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70090-0
The paper
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M.-O., Jicha, G. A., Nordberg, A., . . . Cummings, J. L. (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70090-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.